BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,295,360 | +222.1% | 2,728,737 | +248.5% | 0.10% | +212.9% |
| Q2 2023 | $2,575,715 | +2.8% | 782,892 | -0.6% | 0.03% | -8.8% |
| Q1 2023 | $2,505,602 | -71.9% | 787,925 | -39.0% | 0.03% | -71.7% |
| Q4 2022 | $8,931,637 | +23.9% | 1,290,699 | +13.4% | 0.12% | +18.8% |
| Q3 2022 | $7,207,000 | +118.9% | 1,138,558 | +1006.0% | 0.10% | +65.6% |
| Q2 2021 | $3,292,000 | +216.5% | 102,940 | +198.4% | 0.06% | +165.2% |
| Q1 2021 | $1,040,000 | – | 34,497 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |